Prior approaches to vision correction of refractive error of the eye are less than ideal in at least some respects. Although spectacles and contact lenses can correct vision, these corrective devices may not decrease the onset and severity of myopia and other refractive errors. Similarly, most surgical approaches do not address the underlying causes of ocular development that can result in the eye having refractive error.
In light of the above, improved methods and apparatus of treating refractive error of the eye are needed. Ideally, such methods and apparatus would at least partially address the progression and onset of refractive error of the eye such as myopia.
Embodiments of the present disclosure provide improved methods and apparatus for the treatment of refractive error with light, such as violet light. In some embodiments, a source of light energy such as a source of violet light energy is coupled to a structure configured to contact the eye. The light source and structure are arranged to provide therapeutic amounts of light such as violet light energy to the eye in order to inhibit the progression or onset of refractive error such as myopia. The light source can be configured in many ways and may comprise a radioisotope and a phosphorescent material. The structure configured to contact the eye may comprise a contact lens or an implant.
In a first aspect, an apparatus to treat refractive error of an eye comprises a structure to contact the eye, and a light source coupled to the structure. The light source is configured to direct light energy toward a retina of the eye to treat the refractive error of the eye.
In some embodiments, the light source emits violet light.
In some embodiments, the structure comprises a contact lens, and optionally the light source is one or more of embedded in the contact lens, located on an anterior surface of the contact lens, or located on a posterior surface of the contact lens.
In some embodiments, the light energy comprises violet light energy comprising a wavelength within a range from about 360 nm to about 400 nm.
In some embodiments, the light energy comprises violet light energy and the light source is configured to direct the violet light energy to the retina with an irradiance within a range from about 0.1 mW/cm2 to 5 mW/cm2.
In some embodiments, the light source illuminates a pupil of the eye with light energy in the range 0.1 nit to 10 nits and optionally within the range from 0.5 nits to 10 nits.
In some embodiments, the contact lens comprises one or more of a structure anterior to the light source to reflect light to the retina of the eye, a structure posterior to the light source to focus light onto the retina of the eye, a lens structure posterior to the light source to focus light onto the retina of the eye, or a diffractive structure posterior to the light source to diffract light toward the retina of the eye.
In some embodiments, the contact lens comprises a lens body, the lens body comprising one or more of a soft contact lens, a hydrogel contact lens, a hard contact lens, a rigid gas permeable contact lens, a polymethyl methacrylate contact lens, or an orthokeratology contact lens.
In some embodiments, the light energy comprises light energy violet light energy and the contact lens is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye.
In some embodiments, the structure comprises a contact lens comprising a posterior surface comprising a posterior radius of curvature sized to fit a cornea of the eye, and an anterior surface comprising an anterior radius of curvature configured to correct vision of the eye, and optionally the anterior surface comprises a second anterior radius of curvature oriented in relation to the anterior radius of curvature to correct an astigmatism of the eye.
In some embodiments, the structure to contact the eye comprises an implantable structure and the implantable structure comprises a covering disposed over the light source, and optionally the implant is configured to be turned on and off by a person who received the implant.
In some embodiments, the light source comprises one or more of a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, or a phosphorescent material, and optionally the radioactive material comprises tritium or radium.
In some embodiments, the structure to contact the eye comprises an optically transmissive material comprising a transmittance of at least 40% at 360 nm.
In some embodiments, the light source is arranged in a pattern on the structure to contact the eye, the pattern comprising one or more of: a spatial pattern on the structure to contact the eye, a spatial pattern located on an optically used portion of a contact lens, a spatial pattern on an inner portion of the contact lens to transmit light to the retina when the pupil constricts, a circular pattern, or a radial pattern, and optionally the structure to contact the eye comprises a contact lens.
In some embodiments, the apparatus comprises a contact lens comprising a posterior surface shaped to receive a cornea of the eye, a contact lens material comprising an index of refraction configured to transmit violet light from the source toward the retina, the contact lens comprising an anterior surface shaped to correct a refractive error of the eye in combination with the index of refraction and the posterior surface, and optionally the contact lens is configured to correct higher order aberrations comprising optical aberrations above third order, and optionally the contact lens comprises a multifocal contact lens configured to correct presbyopia.
In another aspect, a method comprises treating an eye with the apparatus of any one of the preceding claims.
All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
The methods and apparatus disclosed herein are well suited for combination with prior approaches to vision correction. For example, the structure to contact the eye may comprise a contact lens or an implant. Such structure may function normally to correct refractive errors and focus light into the eye, while the light source coupled to the structure may emit light such as violet light toward a retina of the eye to treat the refractive error of the eye. In some embodiments, such emission of violet light and violet light received by the eye may be controlled at a level so that there may not be noticeable influence on the functions of the eye.
In some embodiments, the apparatuses and methods disclosed herein are configured to prevent progression or onset of refractive errors in the eye(s). In some embodiments, the apparatuses and methods disclosed herein are configured to treat or improve refractive conditions in the eye(s). In some embodiments, the apparatuses and methods herein promote a curvature change to the cornea of the eye thereby improving refractive conditions in the eye(s), for example with orthokeratology assisted by light such as violet light. In some embodiments, the apparatuses and methods herein inhibit inappropriate increases or allow controlled amounts of increase to the axial length of the eye thereby reducing refractive errors in the eye(s) such as myopia.
In some embodiments, an apparatus to treat refractive error of an eye comprises: a structure to contact the eye; a light source coupled to the structure; wherein the light source is configured to emit violet light energy toward a retina of the eye to treat the refractive error of the eye. In some embodiments, the structure comprises a contact lens. The light source can be embedded in the contact lens, on an anterior surface of the contact lens, or on a posterior surface of the contact lens and combinations thereof. In some embodiments, the violet light comprises a wavelength within a range from about 360 nm to about 400 nm. In some embodiments, the light source is configured to direct violet light energy to the retina with a luminance is less than 5 mW/cm2. In some embodiments, the light source illuminates the pupil of the eye with light energy in the range from 0.1 nit to 10 nit (candelas per square meter), preferably from 0.5 nit to 2 nits. In some embodiments, the contact lens comprises a structure anterior to the light source to reflect light to the retina of the eye, a structure posterior to the light source to focus light onto the retina of the eye, a lens structure posterior to the light source to focus light onto the retina of the eye, or a diffractive structure posterior to the light source to diffract light toward the retina of the eye, and combinations thereof. In some embodiments, the contact lens comprises a lens body, in which the lens body comprises a soft contact lens, a hydrogel contact lens, a hard contact lens, a rigid gas permeable contact lens, a polymethyl methacrylate contact lens, or an orthokeratology contact lens, and combinations thereof. In some embodiments, the contact lens is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye. In some embodiments, the structure comprises a contact lens comprising a posterior surface comprising a posterior radius of curvature sized to fit a cornea of the eye, and an anterior surface comprising an anterior radius of curvature configured to correct vision of the eye. In some embodiments, the anterior surface comprises a second anterior radius of curvature oriented in relation to the anterior radius of curvature to correct an astigmatism of the eye.
In some embodiments, the structure to contact the eye comprises an implantable structure, in which the implantable structure comprises a covering disposed over the light source. The implant can be configured to be turned on and off by a person who received the implant.
The light source can be configured in many ways. In some embodiments, the light source comprises a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, or a phosphorescent material and combinations thereof. The radioactive material may comprise tritium or radium, for example.
In some embodiments, the structure to contact the eye comprises an optically transmissive material comprising a transmittance of at least 40% at 360 nm.
In some embodiments, the light source is arranged in a spatial pattern on the structure to contact the eye. The spatial pattern can be located on an optically used portion of a contact lens, on an inner portion of the contact lens to transmit light to the retina when the pupil constricts, or in a circular pattern or a radial pattern on the contact lens, and combinations thereof.
In some embodiments, the apparatus comprises a contact lens comprising a posterior surface shaped to receive a cornea of the eye, a contact lens material comprising an index of refraction and configured to transmit violet light from the source toward the retina, an anterior surface shaped to correct a refractive error of the eye in combination with the index of refraction and the posterior surface. In some embodiments, the contact lens is configured to correct higher order aberrations comprising optical aberrations above third order, and the contact lens may comprise a multifocal contact lens configured to correct presbyopia.
In some embodiments, a method of treating the eye comprises treating an eye with the apparatus(es) as disclosed herein, such as a contact lens or an implant as disclosed herein.
Referring to
In some embodiments, the contact lens material has an index of refraction and is configured to transmit violet light from the source toward the retina. In some embodiments, the structure to contact the eye 101 has an optically transmissive material comprising a transmittance of at least 30%, 40%, 50%, or 60% at one or more of 350 nm, 360 nm, 370 nm, 380 nm, 390 nm, or 400 nm. In some embodiments, the transmittance is at least 30%, 40%, 50%, or 60% in the entire range from 350 nm to 400 nm.
In some embodiments, the apparatus 100 includes the light source 102 that is coupled to the structure 101. The light source 102 may comprise a plurality of light sources. In some embodiments, the light source is embedded in the structure, and the light source may be embedded in one or more locations of the structure. Such locations may include the optically used portion of the lens. For example, the light source can be located anywhere on an anterior surface 101a of the contact lens 101, or on a posterior surface 101b of the contact lens and combinations thereof. In some embodiments, the light source may be spatially distributed in various patterns. In some embodiments, the spatial pattern may be located on an optically used portion of a contact lens, on an inner portion of the contact lens, or both, to transmit light to the retina (e.g., when the pupil constricts). In some embodiments, the light source may be distributed or in a circular pattern or a radial pattern on the contact lens, and combinations thereof. As shown in
In some embodiments, the light source is configured to emit optical energy toward a retina of the eye to treat the refractive error of the eye. As shown in
In some embodiments, the structure to contact the eye 101 comprises an implantable structure which may comprise a covering disposed over the light source and optionally wherein the implant is configured to be turned on and off, for example, by a person who received the implant or by a trigger external to the implant such as intensity of ambient light detected by the implant.
In some embodiments, the contact lens 101 or the implant is configured to direct the violet light energy onto a cornea and toward the retina with an amount sufficient to promote a curvature change to the cornea of the eye. In some embodiments, the light source is configured to emit the light at a substantially constant level (e.g. within 25%) for a pre-determined period of time, e.g., for at least 12 hours, 1 day, 1 week, 2 weeks, 1 month, or even longer. In some embodiments, the light source is configured to emit the light when triggered by an external trigger. Non-limiting exemplary triggers may include ambient light, opening or closing of the eyelid, a temperature at the light source, etc. In some embodiments, the light source is configured to remain substantially fixed in its spatial location relative to the eye of the patient.
In some embodiments, the light source 102 is configured to direct violet light energy to the retina with a luminance. The light source may have a radioluminescent light source, a light emitting diode, a laser diode, a radioactive material, a phosphorescent material, or a chemiluminescent compound, and combinations thereof. In some embodiments, the radioactive material includes tritium and/or radium.
In some embodiments, the irradiance (energy per unit area) of the violet light (e.g., having a wavelength within the range of 350 nm to 400 nm) emitted from the light source and/or that reaches the eye is not particularly limited. In some embodiments, the irradiance is preferably determined by taking into consideration the effect of the on the human eye and skin, and the duration of the exposure. When light is emitted toward the eye for a long period of time for the purpose of myopia prevention, the irradiance relates to the light emission time as well, and may be increased if the time is short, but is preferably decreased if the time is long. In some embodiments, the irradiance may be 20.0 mW/cm2 or less. In some embodiments, the irradiance may be 10.0 mW/cm2 or less. In some embodiments, the irradiance may be 80.0 mW/cm2 or less. In some embodiments, the irradiance may be 5.0 mW/cm2 or less. In some embodiments, the preferred irradiance is 3.0 mW/cm2 or less. In some embodiments, the irradiance is preferably 2.0 mW/cm2 or less, and is preferably decreased to 1.0 mW/cm2, 0.5 mW/cm2 or less, 0.1 mW/cm2 or less, or 0.05 mW/cm2 or less as the time increases. The irradiance may comprise an amount within a range defined by any two of the preceding values. The irradiance can be measured using a known method. It should be noted that “irradiance” indicates the intensity or energy of the light that enters or reaches the eye.
In some embodiments, the structure to contact the eye includes apiece of eyewear such as an eyeglass, or a goggle.
The presently disclosed methods and apparatus are well suited for combination with many types of lenses, such as one or more of: smart contact lenses, contact lenses with antennas and sensors, contact lenses with integrated pulse oximeters, contact lenses with phase map displays, electro-optic contact lenses, contact lenses with flexible conductors, autonomous eye tracking contact lenses, electrochromic contact lenses, dynamic diffractive liquid crystal lenses, automatic accommodation lenses, image display lenses with programmable phase maps, lenses with tear activated micro batteries, tear film sensing contact lenses, lenses with multi-colored LED arrays, contact lenses with capacitive sensing, lenses to detect overlap of an ophthalmic device by an eyelid, lenses with active accommodation, lenses with electrochemical sensors, lenses with enzymes and sensors, lenses including dynamic visual field modulation, lenses for measuring pyruvate, lenses for measuring urea, lenses for measuring glucose, lenses with tear fluid conductivity sensors, lenses with near eye displays with phase maps, or lenses with electrochemical sensor chips.
While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
This application is a 371 national phase of PCT/US2019/030682, filed May 3, 2019, and claims the benefit under 35 U.S.C. § 119 (e) of United States Provisional Application No. 62/669,580, filed May 10, 2018, entitled “METHODS AND APPARATUSES OF TREATING REFRACTIVE ERROR OF THE EYE”, the disclosures of which are incorporated, in their entirety, by this reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/030682 | 5/3/2019 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2019/217241 | 11/14/2019 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2350386 | Christman | Jun 1944 | A |
6516808 | Schulman | Feb 2003 | B2 |
7018040 | Blum | Mar 2006 | B2 |
8057034 | Ho | Nov 2011 | B2 |
8246167 | Legerton | Aug 2012 | B2 |
8432124 | Foster | Apr 2013 | B2 |
8662664 | Artal Soriano | Mar 2014 | B2 |
8857983 | Pugh | Oct 2014 | B2 |
8960899 | Etzkorn | Feb 2015 | B2 |
9054079 | Etzkorn | Jun 2015 | B2 |
9176332 | Etzkorn | Nov 2015 | B1 |
9345813 | Hogg | May 2016 | B2 |
9482882 | Hanover | Nov 2016 | B1 |
9482883 | Meisenholder | Nov 2016 | B1 |
9726904 | Lin | Aug 2017 | B1 |
9763827 | Kelleher | Sep 2017 | B2 |
9885884 | Drobe | Feb 2018 | B2 |
9889615 | Pugh | Feb 2018 | B2 |
9918894 | Lam | Mar 2018 | B2 |
9962071 | Yates | May 2018 | B2 |
10133092 | Tsubota | Nov 2018 | B2 |
10139521 | Tran | Nov 2018 | B2 |
10146067 | Tsai | Dec 2018 | B2 |
10231897 | Tse | Mar 2019 | B2 |
10268050 | To | Apr 2019 | B2 |
10359648 | Kim | Jul 2019 | B2 |
10591745 | Lin | Mar 2020 | B1 |
10788686 | Tsai | Sep 2020 | B2 |
10884264 | Hones | Jan 2021 | B2 |
10921612 | Zhou | Feb 2021 | B2 |
10993515 | Kim | May 2021 | B1 |
11000186 | Linder | May 2021 | B2 |
11187921 | Zhou | Nov 2021 | B2 |
11219287 | Kim | Jan 2022 | B1 |
11275259 | Kubota | Mar 2022 | B2 |
11281022 | Buscemi | Mar 2022 | B2 |
11320674 | Kubota | May 2022 | B2 |
11358001 | Kubota | Jun 2022 | B2 |
11366339 | Kubota | Jun 2022 | B2 |
11366341 | Kubota | Jun 2022 | B1 |
11388968 | Dabov | Jul 2022 | B2 |
11395959 | Stemple | Jul 2022 | B2 |
11402662 | Wyss | Aug 2022 | B2 |
11409136 | Kubota | Aug 2022 | B1 |
11415818 | Olgun | Aug 2022 | B2 |
11444488 | Bohn | Sep 2022 | B2 |
11446514 | Bahmani | Sep 2022 | B2 |
11460720 | Kubota | Oct 2022 | B1 |
11467423 | Buscemi | Oct 2022 | B2 |
11467426 | Kubota | Oct 2022 | B2 |
11467428 | Kubota | Oct 2022 | B2 |
11470936 | Kim | Oct 2022 | B2 |
11480813 | Kubota | Oct 2022 | B2 |
11531216 | Kubota | Dec 2022 | B2 |
11583696 | Kubota | Feb 2023 | B2 |
11619831 | Wyss | Apr 2023 | B2 |
11630329 | Kubota | Apr 2023 | B2 |
11656483 | Ice | May 2023 | B2 |
11681162 | Zhou | Jun 2023 | B2 |
11681164 | Jamshidi | Jun 2023 | B2 |
11693259 | Buscemi | Jul 2023 | B2 |
11719957 | Kubota | Aug 2023 | B2 |
11733545 | Kubota | Aug 2023 | B2 |
11777340 | Kubota | Oct 2023 | B2 |
11971615 | Kubota | Apr 2024 | B2 |
11986669 | Kubota | May 2024 | B2 |
20020186345 | Duppstadt | Dec 2002 | A1 |
20040237971 | Radhakrishnan | Dec 2004 | A1 |
20050258053 | Sieg | Nov 2005 | A1 |
20060082729 | To | Apr 2006 | A1 |
20060227067 | Iwasaki | Oct 2006 | A1 |
20070115431 | Smith, III | May 2007 | A1 |
20070153231 | Iuliano | Jul 2007 | A1 |
20070281752 | Lewis | Dec 2007 | A1 |
20080231799 | Iuliano | Sep 2008 | A1 |
20080231801 | Iuliano | Sep 2008 | A1 |
20080291391 | Meyers | Nov 2008 | A1 |
20080309882 | Thorn | Dec 2008 | A1 |
20090187242 | Weeber | Jul 2009 | A1 |
20090201460 | Blum | Aug 2009 | A1 |
20090204207 | Blum | Aug 2009 | A1 |
20100076417 | Suckewer | Mar 2010 | A1 |
20100294675 | Mangano | Nov 2010 | A1 |
20100296058 | Ho | Nov 2010 | A1 |
20110085129 | Legerton | Apr 2011 | A1 |
20110153012 | Legerton | Jun 2011 | A1 |
20110202114 | Kessel | Aug 2011 | A1 |
20120055817 | Newman | Mar 2012 | A1 |
20120199995 | Pugh | Aug 2012 | A1 |
20120206485 | Osterhout | Aug 2012 | A1 |
20120212399 | Border | Aug 2012 | A1 |
20120215291 | Pugh | Aug 2012 | A1 |
20130027655 | Blum | Jan 2013 | A1 |
20130072828 | Sweis | Mar 2013 | A1 |
20130135578 | Pugh | May 2013 | A1 |
20130194540 | Pugh | Aug 2013 | A1 |
20130278887 | Legerton | Oct 2013 | A1 |
20130317487 | Luttrull | Nov 2013 | A1 |
20140039361 | Siu | Feb 2014 | A1 |
20140085601 | Etzkorn | Mar 2014 | A1 |
20140194773 | Pletcher | Jul 2014 | A1 |
20140218647 | Blum | Aug 2014 | A1 |
20140240665 | Pugh | Aug 2014 | A1 |
20140268029 | Pugh | Sep 2014 | A1 |
20140277291 | Pugh | Sep 2014 | A1 |
20140306361 | Pugh | Oct 2014 | A1 |
20140379054 | Cooper et al. | Dec 2014 | A1 |
20150018599 | Legerton | Jan 2015 | A1 |
20150057701 | Kelleher | Feb 2015 | A1 |
20150109574 | Tse | Apr 2015 | A1 |
20150160477 | Dai | Jun 2015 | A1 |
20150200554 | Marks | Jul 2015 | A1 |
20150241706 | Schowengerdt | Aug 2015 | A1 |
20160016004 | Hudson | Jan 2016 | A1 |
20160056498 | Flitsch | Feb 2016 | A1 |
20160067037 | Rosen | Mar 2016 | A1 |
20160067087 | Tedford | Mar 2016 | A1 |
20160091737 | Kim | Mar 2016 | A1 |
20160143801 | Yin | May 2016 | A1 |
20160158486 | Colbaugh | Jun 2016 | A1 |
20160270656 | Samec | Sep 2016 | A1 |
20160299357 | Hayashi | Oct 2016 | A1 |
20160377884 | Lau | Dec 2016 | A1 |
20170000326 | Samec | Jan 2017 | A1 |
20170001032 | Samec | Jan 2017 | A1 |
20170010480 | Blum | Jan 2017 | A1 |
20170014074 | Etzkorn | Jan 2017 | A1 |
20170055823 | Lu | Mar 2017 | A1 |
20170072218 | Rucker | Mar 2017 | A1 |
20170115512 | Pugh | Apr 2017 | A1 |
20170184875 | Newman | Jun 2017 | A1 |
20170270636 | Shtukater | Sep 2017 | A1 |
20170276963 | Brennan | Sep 2017 | A1 |
20170307779 | Marullo | Oct 2017 | A1 |
20170367879 | Lopath | Dec 2017 | A1 |
20180017810 | Wu | Jan 2018 | A1 |
20180017814 | Tuan | Jan 2018 | A1 |
20180052319 | Mccabe | Feb 2018 | A1 |
20180055351 | Yates | Mar 2018 | A1 |
20180074322 | Rousseau | Mar 2018 | A1 |
20180090958 | Steger | Mar 2018 | A1 |
20180092738 | Tai | Apr 2018 | A1 |
20180136486 | Macnamara | May 2018 | A1 |
20180136491 | Ashwood | May 2018 | A1 |
20180161231 | Tse | Jun 2018 | A1 |
20180173010 | Harant | Jun 2018 | A1 |
20180188556 | Portney | Jul 2018 | A1 |
20180221140 | Rosen | Aug 2018 | A1 |
20180264284 | Alvarez | Sep 2018 | A1 |
20180275427 | Lau | Sep 2018 | A1 |
20180345034 | Butzloff | Dec 2018 | A1 |
20190033618 | Choi | Jan 2019 | A1 |
20190033619 | Neitz | Jan 2019 | A1 |
20190049730 | Miller | Feb 2019 | A1 |
20190076241 | Alarcon Heredia | Mar 2019 | A1 |
20190092545 | Oag | Mar 2019 | A1 |
20190129204 | Tsubota | May 2019 | A1 |
20190227342 | Brennan | Jul 2019 | A1 |
20190235279 | Hones | Aug 2019 | A1 |
20190247675 | Legerton | Aug 2019 | A1 |
20190250413 | Martin | Aug 2019 | A1 |
20190250432 | Kim | Aug 2019 | A1 |
20190314147 | Blum | Oct 2019 | A1 |
20190318589 | Howell | Oct 2019 | A1 |
20200026082 | Park | Jan 2020 | A1 |
20200033637 | Jamshidi | Jan 2020 | A1 |
20200073148 | Alhaideri | Mar 2020 | A1 |
20200089023 | Zhou | Mar 2020 | A1 |
20200108272 | Bahmani | Apr 2020 | A1 |
20200110265 | Serdarevic | Apr 2020 | A1 |
20200133024 | Paune Fabre | Apr 2020 | A1 |
20200142219 | Rousseau | May 2020 | A1 |
20200264455 | Olgun | Aug 2020 | A1 |
20200364992 | Howell | Nov 2020 | A1 |
20210018762 | Zheleznyak | Jan 2021 | A1 |
20210031051 | Kubota | Feb 2021 | A1 |
20210048690 | Guillot | Feb 2021 | A1 |
20210231977 | Zhou | Jul 2021 | A1 |
20210263336 | Gupta | Aug 2021 | A1 |
20210298440 | Kim | Sep 2021 | A1 |
20210329764 | Linder | Oct 2021 | A1 |
20210356767 | Kubota | Nov 2021 | A1 |
20210376661 | Bohn | Dec 2021 | A1 |
20210379399 | Buscemi | Dec 2021 | A1 |
20210382325 | Kubota | Dec 2021 | A1 |
20210382326 | Kubota | Dec 2021 | A1 |
20210389607 | Buscemi | Dec 2021 | A1 |
20220057651 | Segre | Feb 2022 | A1 |
20220107508 | Zhou | Apr 2022 | A1 |
20220128842 | Ice | Apr 2022 | A1 |
20220179213 | Zhou | Jun 2022 | A1 |
20220197059 | Zhou | Jun 2022 | A1 |
20220231523 | Bristol | Jul 2022 | A1 |
20220257972 | Kubota | Aug 2022 | A1 |
20220299795 | Wyss | Sep 2022 | A1 |
20220390766 | Kubota | Dec 2022 | A1 |
20220390768 | Kubota | Dec 2022 | A1 |
20220397775 | Bahmani | Dec 2022 | A1 |
20220404641 | Kubota | Dec 2022 | A1 |
20220413318 | Kubota | Dec 2022 | A1 |
20230026567 | Buscemi | Jan 2023 | A1 |
20230089006 | Kubota | Mar 2023 | A1 |
20230324717 | Kubota | Oct 2023 | A1 |
Number | Date | Country |
---|---|---|
215494397 | Jan 2022 | CN |
3153139 | Apr 2017 | EP |
3232254 | Oct 2017 | EP |
3255478 | Dec 2017 | EP |
3413116 | Dec 2018 | EP |
3640713 | Apr 2020 | EP |
2006292883 | Oct 2006 | JP |
2011518355 | Jun 2011 | JP |
2014508585 | Apr 2014 | JP |
2017173847 | Sep 2017 | JP |
2017219847 | Dec 2017 | JP |
20180038359 | Apr 2018 | KR |
20180038359 | Apr 2018 | KR |
M356929 | May 2009 | TW |
201234072 | Aug 2012 | TW |
201734580 | Oct 2017 | TW |
2009074638 | Jun 2009 | WO |
2009074638 | Jun 2009 | WO |
2009121810 | Oct 2009 | WO |
2009129528 | Oct 2009 | WO |
2010015255 | Feb 2010 | WO |
2010043599 | Apr 2010 | WO |
2011008846 | Jan 2011 | WO |
2011089042 | Jul 2011 | WO |
2011153158 | Dec 2011 | WO |
2011163559 | Dec 2011 | WO |
2012018583 | Feb 2012 | WO |
2012037019 | Mar 2012 | WO |
2012106542 | Aug 2012 | WO |
2012118777 | Sep 2012 | WO |
2012129210 | Sep 2012 | WO |
2012136470 | Oct 2012 | WO |
2012138426 | Oct 2012 | WO |
2013059195 | Apr 2013 | WO |
2013059656 | Apr 2013 | WO |
2013059663 | Apr 2013 | WO |
2013087518 | Jun 2013 | WO |
2013112748 | Aug 2013 | WO |
2013112803 | Aug 2013 | WO |
2013112862 | Aug 2013 | WO |
2013112868 | Aug 2013 | WO |
2013130803 | Sep 2013 | WO |
2013151728 | Oct 2013 | WO |
2014004836 | Jan 2014 | WO |
2014004839 | Jan 2014 | WO |
2014018104 | Jan 2014 | WO |
2014033035 | Mar 2014 | WO |
2014050879 | Apr 2014 | WO |
2014052012 | Apr 2014 | WO |
2014117173 | Jul 2014 | WO |
2014120928 | Aug 2014 | WO |
2014161002 | Oct 2014 | WO |
2014178221 | Nov 2014 | WO |
2014191460 | Dec 2014 | WO |
2015063097 | May 2015 | WO |
2015095891 | Jun 2015 | WO |
2015105881 | Jul 2015 | WO |
2015164564 | Oct 2015 | WO |
2015186723 | Dec 2015 | WO |
2016019346 | Feb 2016 | WO |
2016019351 | Feb 2016 | WO |
2017039672 | Mar 2017 | WO |
2017083770 | May 2017 | WO |
2017083774 | May 2017 | WO |
2017094886 | Jun 2017 | WO |
2017168122 | Oct 2017 | WO |
2018014712 | Jan 2018 | WO |
2018014712 | Jan 2018 | WO |
2018014960 | Jan 2018 | WO |
2018057804 | Mar 2018 | WO |
2018075229 | Apr 2018 | WO |
2018085576 | May 2018 | WO |
2018088980 | May 2018 | WO |
2018089699 | May 2018 | WO |
2018208724 | Nov 2018 | WO |
2019100941 | May 2019 | WO |
2019114463 | Jun 2019 | WO |
2019191510 | Oct 2019 | WO |
2019217241 | Nov 2019 | WO |
2020014074 | Jan 2020 | WO |
2020014613 | Jan 2020 | WO |
2020025355 | Feb 2020 | WO |
2020028177 | Feb 2020 | WO |
2020069232 | Apr 2020 | WO |
2021056018 | Mar 2021 | WO |
2021116449 | Jun 2021 | WO |
2021168481 | Aug 2021 | WO |
2021231684 | Nov 2021 | WO |
2021252318 | Dec 2021 | WO |
2021252319 | Dec 2021 | WO |
2021252320 | Dec 2021 | WO |
2022217193 | Oct 2022 | WO |
2022258572 | Dec 2022 | WO |
Entry |
---|
International Search Report and Written Opinion for International Application No. PCT/US2019/030682, 8 pages (Jul. 17, 2019). |
Lam, Carly Siu Yin, et al., “Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial,” Br. J. Ophthalmol. 0:1-6 (2019). |
Torii, Hidemasa, et al., “Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression,” EBioMedicine 15:210-219 (2017). |
Adler, Daniel, et al., “The possible effect of under correction on myopic progression in children.” Clin Exp Optom., 89:315-321 (2006). |
Aleman, Andrea C., et al.,, “Reading and Myopia: Contrast Polarity Matters,” Scientific Reports, 8 pages (2018). |
Arden, G.B., et al., “Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis,” Vision Research 38:1723-1729 (1998). |
Arden, GB, et al, “Regression of early diabetic macular edema is associated with prevention of dark adaptation”, in Eye, (2011). 25, pp. 1546-1554. |
Benavente-Perez, A., et al., “Axial Eye Growth and Refractive Error Development Can be Modified by Exposing the Peripheral Retina to Relative Myopic or Hyperopic Defocus,” Invest Ophthalmol Vis Sci., 55:6765-6773 (2014). |
Bonar, Jr, et al, “High brightness low power consumption microLED arrays”, in SPIE DigitalLibrary.org/conference-proceedings-of-spie, SPIE OPTO, 2016, San Francisco, California, United States, Abstract Only. |
Carr, Brittany J., et al., “The Science Behind Myopia,” retrieved from https://webvision.med.utah.edu/book/part-xvii-refractive-errors/the-science-behind-myopia-by-brittany-j-carr-and-william-k-stell/, 89 pages (2018). |
Chakraborty, R., et al., “Diurnal Variations in Axial Length, Choroidal Thickness, Intraocular Pressure, and Ocular Biometrics,” IOVS, 52(8):5121-5129 (2011). |
Chakraborty, R., et al., “Hyperopic Defocus and Diurnal Changes in Human Choroid and Axial Length,” Optometry and Visual Science, 90(11):1187-1198 (2013). |
Chakraborty, R., et al., “Monocular Myopic Defocus and Daily Changes in Axial Length and Choroidal Thickness of human Eyes,” Exp Eye Res, 103:47-54 (2012). |
Cooper, J., et al, “Current status of the development and treatment of myopia”, Optometry, 83:179-199 (2012). |
Cooper, J., et al., “A Review of Current Concepts of the Etiology and Treatment of Myopia,” Eye & Contact Lens, 44(4):231-247 (Jul. 2018). |
Demory, B., et al, “Integrated parabolic microlenses on micro LED color pixels”, in Nanotechnology, (2018); 29, 16, pp. 1018, Abstract Only. |
Dolgin, Elle, “The Myopia Boom,” Nature 519:276-278 (2015). |
Edrington, Timothy B., “A literature review: The impact of rotational stabilization methods on toric soft contact lens performance,” Contact Lens & Anterior Eye, 34:104-110 (2011). |
Flitcroft, D.I., “The complex interactions of retinal, optical and environmental factors in myopia aetiology,” 31(6):622-660 (2012). |
Garner, L.F., et al., “Crystalline Lens Power in Myopia,” Optometry and Vision Science, 69:863-865 (1992). |
Gwiazda, Jane, “Treatment Options for Myopia,” retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729053/, Optom Vis Sci., 86(6):624-628 (Jun. 2009). |
Gwiazda, Jane, et al, “A Randomized Clinical Trial of Progressive Addition Lenses versus Single Vision Lenses on the Progression of Myopia in Children”, Invest Ophthalmol Vis Scl, 44:1492-500 [PubMed: 12657584] (2003). |
Hammond, D.S., et al, “Dynamics of active emmetropisation in young chicks—influence of sign and magnitude of imposed defocus” Ophthalmic Physiol Opt. 33:215-222 (2013). |
Henry W., “MicroLED Sources enable diverse ultra-low power applications”, in Photonic Spectra, 2013. |
Jones, D., “Measure Axial Length to Guide Myopia Management,” Review of Myopia Management, 5 pages (Apr. 9, 2020). |
Kur, Joanna, et al., “Light adaptation does not prevent early retinal abnormalities in diabetic rats,” Scientific Reports, 8 pages (Feb. 8, 2016). |
Lagreze, Wolf A., et al., “Preventing Myopia,” retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615392/, Dtsch Arztebl Int., 114(35-36):575-580 (Sep. 2017). |
Leo, Seo-Wei, et al., “An evidence-based update on myopia and interventions to retard its progression,” J AAPOS, 15(2): 181-189 (Apr. 2011). |
Lingley, A.R., et al, : A single pixel wireless contact lens display, in J Micromech. Microeng., 2011; 21, 125014; doi:10.1088/0960-1317/21/12/125014, Abstract Only. |
Martin, J.A., et al., “Predicting and Assessing Visual Performance with Multizone Bifocal Contact Lenses,” Optom Vis Sci, 80(12):812-819 (2003). |
Matkovic, K., et al., “Global Contrast Factor—a New Approach to Image Contrast,” Computational Aesthetics in Graphics, Visualization and Imaging, 9 pages (2005). |
McKeague C, et al. “Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial”, in Trials 2014, 15:246, http://www.trialsjournal.com/content/15/1/246. |
Moreno, I, “Creating a desired lighting pattern with an LED array” in Aug. 2008, Proceedings of SPIE—The International Society for Optical Engineering 7058, DOI: 10.1117/12.795673. |
Moreno, I., “Modeling the radiation pattern of LEDS”, in Optics Express, 2008; 16, 3 pp. 1808. |
Nickla, Debora L., et al., “Brief hyperopic defocus or form deprivation have varying effects on eye growth and ocular rhythms depending on the time-of-day of exposure,” Exp Eye Res. 161:132-142 (Aug. 2017). |
Ramsey, DJ, and Arden, GB, “Hypoxia and dark adaptation in diabetic retinopathy: Interactions, consequences and therapy”, in Microvascular Complications-Retinopathy (JK Sun, ed.), Cur Dab Rep (2015) 15: 118, DOI 10.1007/s11892-015-0686-2, Abstract Only. |
Read, Scott A., et al., “Choroidal changes in human myopia: Insights from optical coherence tomography imaging,” Clin Exp Optom, 16 pages (2018). |
Read, Scott A., et al., “Human Optical Axial Length and Defocus,” IOVS, 51(12):6262-6269 (2010). |
Shivaprasad, S, et al, “Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial,” in www.thelancet.com/diabetes-endocrinology vol. 6, pp. 382-391 ( May 2018). |
Smith, III, Earl L., “Optical treatment strategies to slow myopia progression: Effects of the visual extent of the optical treatment zone,” retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624048/, Exp Eye Res., 114:77-88 (Sep. 2013). |
Srinivasan, S., “Ocular axes and angles: Time for better understanding,” J. Cataract Refract. Surg., 42:351-352 (Mar. 2016). |
Wallman, Josh, et al., “Homeostasis of Eye Growth and the Question of Myopia,” Neuron, 43:447-468 (2004). |
Wolffsohn, James A., et al., “Impact of Soft Contact Lens Edge Design and Midperipheral Lens Shape on the Epithelium and Its Indentation With Lens Mobility,” IOVS, 54(9):6190-6196 (2013). |
Haglund, Erik, et al., “Multi-wavelength VCSEL arrays using high-contrast gratings,” Proc. of SPIE vol. 10113, 7 pages (2017). |
International Application No. PCT/US2021/036100, filedJune 7, 2021 (86 pages). |
International Patent Application No. PCT/US2021/032162, filed May 13, 2021 (58 pages). |
International Patent Application No. PCT/US2021/036102, filed Jun. 7, 2021 (67 pages). |
International Patent Application No. PCT/US2021/070166, filed Feb. 19, 2021 (79 pages). |
Jayaraman, V., et al., “Recent Advances in MEMS-VCSELs for High Performance Structural and Functional SS-OCT Imaging,” Proc. of SPIE vol. 8934, retrieved from http://proceedings.spiedigitallibrary.org/ on Dec. 1, 2015 (2014). |
U.S. Appl. No. 17/304,666, filed Jun. 24, 2021 (67 pages). |
U.S. Appl. No. 17/302,479, filed May 4, 2021 (60 pages). |
U.S. Appl. No. 17/302,827, filed May 13, 2021 (52 pages). |
U.S. Appl. No. 17/303,889, filed Jun. 9, 2021 (69 pages). |
U.S. Appl. No. 17/304,630, filed Jun. 23, 2021 (68 pages). |
U.S. Appl. No. 17/304,691, filed Jun. 24, 2021 (88 pages). |
Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. Jul. 2021; 83:100923. Epub Nov. 27, 2020. |
Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochran Database Syst Rev. Dec. 7, 2011; (12):CD004916. |
Zhou WJ, Zhang YY, Li H, Wu YF, Xu J, Lv S, Li G, Liu SC, Song SF. Five-year progression of refractive errors and incidence of myopia in school-aged children in western China. J Epidemiol. Jul. 5, 2016; 26(7):386-95. Epub Feb. 13, 2016. |
“Design Considerations for Overmolding and Insert Molding,” Proto Labs, retrieved May 6, 2024 from chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://vertassets.blob.core.windows.net/download/777c536d/777c536d-f935-4a3a-aa9e-bff37143c1dd/pl_designconsiderations_for_om_im_wp_final.pdf, applicant believes that the teachings of this reference was known prior to Apr. 6, 2021. |
“What Is Insert Molding? Process, Considerations & Applications,” retrieved May 6, 2024 from https://www.rapiddirect.com/blog/what-is-insert-molding/, applicant believes that the teachings of these reference was known prior to Apr. 6, 2021. |
Number | Date | Country | |
---|---|---|---|
20210069524 A1 | Mar 2021 | US |
Number | Date | Country | |
---|---|---|---|
62669580 | May 2018 | US |